Cargando…

Genetic Analysis Can Surrogate the Treatment Strategies in Patients with Pancreatic Cancer

Detalles Bibliográficos
Autor principal:	Kim, Dong Uk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860033/ https://www.ncbi.nlm.nih.gov/pubmed/31724388 http://dx.doi.org/10.5009/gnl19319

Ejemplares similares

Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
por: Kim, Dong Uk
Publicado: (2022)

Does the Cytogenetic Analysis Using Fluorescence In Situ Hybridization Improve the Preoperative Diagnostic Accuracy of Pancreatic Ductal Adenocarcinoma?
por: Kim, Dong Uk
Publicado: (2020)

Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments”
por: Coppola, Alessandro, et al.
Publicado: (2022)

Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment
por: Mukherjee, Shibani, et al.
Publicado: (2020)

Insulin Resistance: Quest for Surrogate Markers
por: Mahajan, Rajiv
Publicado: (2017)

Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer
por: Forbes, Lindsay M., et al.
Publicado: (2021)

Surrogate Measures of Insulin Resistance in an Apparently Healthy Population: a Simpler and Easier, yet Reliable Index
por: Kim, Dong Sun
Publicado: (2018)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Novel Strategies to Address Critical Challenges in Pancreatic Cancer
por: Puik, Jisce R., et al.
Publicado: (2022)

How Surrogate and Chemical Genetics in Model Organisms Can Suggest Therapies for Human Genetic Diseases
por: Strynatka, Katherine A., et al.
Publicado: (2018)

Defining vitamin D deficiency, using surrogate markers
por: Garg, M. K., et al.
Publicado: (2013)

Biomarkers as Surrogates for Coronary Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease
por: Vani, Anish, et al.
Publicado: (2018)

Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges
por: Pastorino, Lorenza, et al.
Publicado: (2023)

Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases
por: Kim, Byeong-Gon, et al.
Publicado: (2021)

Genetic Mutation Analysis Can Supplement Clinically Confirmed Hereditary Hemorrhagic Telangiectasia Populations
por: Kim, Seon Tae
Publicado: (2019)

Right Atrial Strain as a Surrogate Marker for Right Ventricular Function in Patients with Heart Failure
por: Kang, Min-Kyung
Publicado: (2021)

Tobacco use among medical students and surrogate control of tobacco in India
por: Singh, Virendra
Publicado: (2011)

Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?
por: Tarantino, Giovanni
Publicado: (2013)

RDW as a Surrogate Marker for Active Crohn's Disease: Potential Utility
por: Cravo, Marilia
Publicado: (2016)

What Is the Optimal Surrogate Indicator for a Miss Rate of Adenoma in Colonoscopy?
por: Hong, Seung Wook, et al.
Publicado: (2022)

Number of Missing Teeth as a Surrogate Marker for Risk of Atherosclerotic Disease
por: Ono, Takahiro
Publicado: (2023)

A mechanistic insight into severe COPD: the nose as a surrogate for the airways
por: Yao, Xin, et al.
Publicado: (2023)

Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
por: Kim, Dong Uk
Publicado: (2023)

Screening for pancreatic cancer in individuals with genetic susceptibility
por: Grützmann, Robert, et al.
Publicado: (2023)

Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
por: Szarvas, Tibor, et al.
Publicado: (2019)

Is Dynamic Left Ventricular Dyssynchrony a Novel Surrogate Marker in the Patient with Hypertension?
por: Chung, Wook-Jin
Publicado: (2012)

The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”?
por: Yang, Yinmo, et al.
Publicado: (2022)

Can Ultrasound Be as a Surrogate Marker for Diagnosing a Papillary Thyroid Cancer? Comparison with BRAF Mutation Analysis
por: Seo, Jae Young, et al.
Publicado: (2014)

Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma?
por: Kim, Dong Uk
Publicado: (2023)

Articulating laparoscopic instruments: are they a breakthrough that can overcome current limitations in laparoscopic gastric cancer surgery?
por: Son, Sang-Yong, et al.
Publicado: (2021)

Cardiac risk assessment in asymptomatic diabetes: Combing different imaging modalities and surrogate markers?
por: Scholte, Arthur J. H. A.
Publicado: (2011)

Surrogate endpoints in global health research: still searching for killer apps and silver bullets?
por: Pai, Madhukar, et al.
Publicado: (2018)

Editorial Comment: Phase angle from bioimpedance measurements as a surrogate of cardiovascular disease
por: Ward, Leigh C.
Publicado: (2022)

Plasma Cell Neoplasms: Genetics, Pathobiology, and New Therapeutic Strategies
por: Lee, Dong Soon, et al.
Publicado: (2014)

The End TB Strategy: India can blaze the trail
por: Pai, Madhukar
Publicado: (2015)

Chemosensitization strategies for the treatment of lung cancer
por: Senovilla, Laura, et al.
Publicado: (2015)

Evolution of treatment strategies for gastric cancer
por: Kakeji, Yoshihiro
Publicado: (2023)

Evaluating surrogates of genetic diversity for conservation planning
por: Hanson, Jeffrey O., et al.
Publicado: (2020)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Surrogate Marker for Major Cardiac Adverse Events in Japanese Patients
por: Komatsu, Tomohiro, et al.
Publicado: (2021)

Pancreatic cancer screening in high-risk individuals with genetic susceptibility
por: Andersson, Roland, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vgte2qqtosccsf55c4al2me35k